The race to develop a diagnostic tool for rapid testing is critical. Time is crucial in containing the spread. GLC is in development of their patent-pending Tailorable Graphene Virus Biosensor, which is an easy-to-use and simple virus detection kit. Our graphene technology can be tailored for any virus or other respiratory infection.

Having a rapid diagnostic response test kit, using saliva, enables our economy to reopen by utilizing a non-intrusive testing tool on a massive scale. This at-the-door technology allows for businesses to reopen reducing the stringent physical distancing requirements. Businesses can now ensure with a confidence their clientele are comfortably diagnosed and society can return to public venues and events.